Cargando…

Mepolizumab therapy in a pediatric patient with eosinophilic granulomatosis with polyangiitis associated with refractory myocarditis

Detalles Bibliográficos
Autores principales: Ulu, Kadir, Çağlayan, Şengül, Çetemen, Ayşen, Çakan, Mustafa, Öner, Taliha, Sözeri, Betül
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish League Against Rheumatism 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481679/
https://www.ncbi.nlm.nih.gov/pubmed/37680517
http://dx.doi.org/10.46497/ArchRheumatol.2023.9823
_version_ 1785102029717241856
author Ulu, Kadir
Çağlayan, Şengül
Çetemen, Ayşen
Çakan, Mustafa
Öner, Taliha
Sözeri, Betül
author_facet Ulu, Kadir
Çağlayan, Şengül
Çetemen, Ayşen
Çakan, Mustafa
Öner, Taliha
Sözeri, Betül
author_sort Ulu, Kadir
collection PubMed
description
format Online
Article
Text
id pubmed-10481679
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Turkish League Against Rheumatism
record_format MEDLINE/PubMed
spelling pubmed-104816792023-09-07 Mepolizumab therapy in a pediatric patient with eosinophilic granulomatosis with polyangiitis associated with refractory myocarditis Ulu, Kadir Çağlayan, Şengül Çetemen, Ayşen Çakan, Mustafa Öner, Taliha Sözeri, Betül Arch Rheumatol Letter Turkish League Against Rheumatism 2022-12-01 /pmc/articles/PMC10481679/ /pubmed/37680517 http://dx.doi.org/10.46497/ArchRheumatol.2023.9823 Text en Copyright © 2023, Turkish League Against Rheumatism https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Letter
Ulu, Kadir
Çağlayan, Şengül
Çetemen, Ayşen
Çakan, Mustafa
Öner, Taliha
Sözeri, Betül
Mepolizumab therapy in a pediatric patient with eosinophilic granulomatosis with polyangiitis associated with refractory myocarditis
title Mepolizumab therapy in a pediatric patient with eosinophilic granulomatosis with polyangiitis associated with refractory myocarditis
title_full Mepolizumab therapy in a pediatric patient with eosinophilic granulomatosis with polyangiitis associated with refractory myocarditis
title_fullStr Mepolizumab therapy in a pediatric patient with eosinophilic granulomatosis with polyangiitis associated with refractory myocarditis
title_full_unstemmed Mepolizumab therapy in a pediatric patient with eosinophilic granulomatosis with polyangiitis associated with refractory myocarditis
title_short Mepolizumab therapy in a pediatric patient with eosinophilic granulomatosis with polyangiitis associated with refractory myocarditis
title_sort mepolizumab therapy in a pediatric patient with eosinophilic granulomatosis with polyangiitis associated with refractory myocarditis
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481679/
https://www.ncbi.nlm.nih.gov/pubmed/37680517
http://dx.doi.org/10.46497/ArchRheumatol.2023.9823
work_keys_str_mv AT ulukadir mepolizumabtherapyinapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisassociatedwithrefractorymyocarditis
AT caglayansengul mepolizumabtherapyinapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisassociatedwithrefractorymyocarditis
AT cetemenaysen mepolizumabtherapyinapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisassociatedwithrefractorymyocarditis
AT cakanmustafa mepolizumabtherapyinapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisassociatedwithrefractorymyocarditis
AT onertaliha mepolizumabtherapyinapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisassociatedwithrefractorymyocarditis
AT sozeribetul mepolizumabtherapyinapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisassociatedwithrefractorymyocarditis